MedPath

Assessment of remission maintenance effect of leukocytapheresis for ulcerative colitis

Not Applicable
Recruiting
Conditions
lcerative colitis
Registration Number
JPRN-UMIN000008905
Lead Sponsor
Tokai University Hachioji Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients under 18 y.o. 2. Patients with either white blood cell count of less than 3,000/mm3, or platelet count of less than 100,000/mm3. 3. Patients with allergic anamnesis or experience or the fear of allergic hypersensitivity reaction. 4. Patients with serious infection or cardiovascular disease or liver disease or kidney disease or respiratory disease or metabolic disease neurologic disease. 5. Patients having received inhibitor of angiotensin converting enzyme. 6. Patients with hypotension (less than maximal blood pressure 80mmHg) 7. Patients who are pregnant or possibly pregnant.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of remission maintained (days)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath